More than 29.5 million Americans ages 12 and older had Alcohol use disorder — the medical term for the disease commonly often called alcoholism — in 2022, when essentially the most recent national data was released.
The disorder is characterised by a pattern of heavy alcohol consumption with lack of control over alcohol consumption despite negative social, occupational, or health consequences.
Deaths on account of excessive alcohol consumption have increased sharply lately, to 178,000 within the United States in 2021, up from 138,000 five years earlier. The strongest increase occurred in the course of the first 12 months of the COVID-19 pandemic.
Alcohol is liable for more deaths as overdoses from opioids and all other substances combined and is liable for 1 in 5 of all deaths in people aged 20 to 49. Alcohol-related deaths can have various causes. These include the long-term effects of alcohol, similar to cancer, liver disease, and heart disease, in addition to its short-term effects, similar to automobile accidents, poisoning, and suicide.
There are many effective treatment options for alcohol use disorders, including psychotherapy, peer support groups similar to: Anonymous alcoholics And SMART recoveryand medicine. I’m a clinical psychologist and neuroscientistand over the past 15 years my research has focused on Evaluation of medicines for alcohol use disorder.
Over this time, I actually have observed significant changes within the scientific understanding and treatment of alcohol use disorders. I’m optimistic that our existing medicines can reach more individuals with this condition, that we are able to higher goal these medicines to the patients most probably to learn from them, and that latest effective medicines are on the horizon.
Alcohol abuse disorders are largely undertreated
With the Beginning of the opioid epidemic Over the past twenty years, medications for opioid use disorders similar to methadone and buprenorphine entered the general public consciousness. However, medications for alcohol addiction are less well-known to the general public and are used less steadily.
While 22% of patients suffer from opioid use disorder Receive medication for treatmentThe rate of drug treatment for alcohol use disorders is far lower. Less than 10% of individuals with alcohol addiction receive treatment every year, and lower than 3% receive medication for it.
Unfortunately, many individuals suffer from alcohol addiction don't recognize it the severity of their alcohol use and its impact on others, and plenty of are unaware that effective medications can be found.
Medications approved to treat alcohol addiction
As of May 2024, three medications have been approved by the Food and Drug Administration to treat alcohol use disorder. The oldest and best known of those drugs is Disulfiram – sold under the brand name Antabuse – a connection that was first utilized in the American rubber industry.
In 1937, a rubber factory doctor observed that employees exposed to disulfiram showed hostile reactions to alcohol, including nausea, vomiting and tachycardia – a rapid heartbeat. Subsequent research found that disulfiram inhibits alcohol metabolism, resulting in… Accumulation of acetaldehyde. This causes many hangover symptoms immediately after drinking alcohol. which makes drinking unpleasant.
Disulfiram is effective in reducing alcohol consumption However, it should be taken orally day by day, limiting its usefulness if patients don’t take it on this schedule.
A recently FDA approved – and simpler – Drug for alcohol addiction is the opioid receptor antagonist naltrexone. It blocks opioid receptors and prevents opioids—each “exogenous” opioid drugs and “endogenous” opioids produced within the brain—from activating these receptors.
It may be surprising that an opioid receptor antagonist is effective in treating alcohol use disorders. However, opioids actually play a key role in alcohol's effect on the neurotransmitter Dopaminewhich underlies the nice effects of alcohol and most other drugs.
Naltrexone reduces dopamine release from alcoholblock a few of them nice effect of drinking. It can be vital reduces cravings for alcohol, probably through its effect on dopamine, which is released in response to signals similar to the sight, smell and taste of alcohol. Naltrexone is effective in reducing heavy alcohol consumption but less effective with complete abstinence from alcohol.
Naltrexone might be taken orally day by day or injected once a month, making it a greater option for patients who can have difficulty taking an oral medication day by day. Interestingly too Reduces heavy alcohol consumption when taken sporadically before expected drinking opportunities. The same opioid antagonist, nalmefene, is approved within the European Union in alcohol addiction.
The third drug approved by the FDA, Acamprosate, also reduces alcohol cravings, but its molecular effects are less well understood. Results of European clinical studies can be found It has been shown to assist people reduce their alcohol consumptionbut results from US studies were less positive.
“Off-label” medications
Several medications have shown encouraging effects on alcohol consumption in randomized controlled trials but should not yet approved by the FDA for the treatment of alcohol use disorders. Instead, they’re used “off-label,” meaning doctors use their discretion to prescribe them for an unapproved indication. The Most promising Medication are approved for the treatment of epilepsy.
These medications look like partially effective for alcohol use disorders Reducing alcohol withdrawal symptoms, a dangerous condition that happens in some people after they abruptly stop heavy drinking. In its most severe form, alcohol withdrawal causes hyperreactivity of the autonomic nervous system, auditory and visual hallucinations, and seizures. These medications include gabapentin, topiramate and baclofen, the latter approved in France in alcohol addiction.
Precision medicine
Unfortunately, each FDA-approved and unapproved alcohol abuse medications have relatively small effects on alcohol consumption. On average, these medications cause individuals who drink heavily most days of the week—that’s, 4 or more drinks per day for ladies, five or more for men—to accomplish that less one or two days per week. However, this average varies significantly between patients – some see a big effect and others see no profit.
A significant current focus of research funded by the National Institute on Alcohol Abuse and Alcoholism on medications for alcohol use disorders has been the usage of a “Precision medicine“Approach to discover patients for whom a specific drug is more more likely to have a big effect.
For example, my work And Other' has found that folks who each drink heavily and smoke cigarettes usually tend to profit from naltrexone. This could also be on account of the additive effects of alcohol and nicotine on dopamine release in reward-related brain regions makes these people particularly more likely to profit from a drug that may block dopamine release from alcohol. Naltrexone also appears to be simpler in people whose drinking is motivated by the will for positive, rewarding effects of alcoholconsistent with its ability to scale back these effects.
Finally, recent research suggests that gabapentin could also be simpler People with a history of alcohol withdrawal. Genes that predict drug effects are also being evaluated, but up to now none have had consistent effects across studies.
At the horizon
The seek for effective medications to treat alcohol addiction is a vital area of current research. The National Institute on Alcohol Abuse and Alcoholism funds a cross-location research programduring which my laboratory participates and has evaluated quite a lot of promising drug candidates Phase 2 and three clinical trials. The FDA typically requires that drugs display effectiveness in a minimum of two Phase 3 trials before they’re approved for a brand new use.
A resurgence of Interest in psychedelic compounds in psychiatry has led to preliminary data suggesting that psilocybin, the energetic ingredient in hallucinogenic mushrooms, Reduce alcohol consumption together with psychotherapy.
Finally, Anecdotal reports of decreased interest in alcohol They have sparked a number of interest in patients taking GLP-1 agonists—drugs that mimic the consequences of glucagon-like peptide 1 (GLP-1), a hormone the body produces after eating Potential of those medications to treat alcohol use disordersThese include Ozempic and Wegovy, that are FDA approved for diabetes and weight reduction. My lab and a number of other others are Conducting trials with these medicationswith results expected in the subsequent one to 2 years.
Alcohol addiction is a devastating disease that urgently needs higher treatments. Approved and off-label medications are currently available. As research into latest medications continues, patients should seek them out Providers who use evidence-based treatments have the best likelihood of success in relation to gaining control over their alcohol consumption.
image credit : theconversation.com